UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 68 filers reported holding UROGEN PHARMA LTD in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48 | +17.1% | 3,421 | -12.3% | 0.00% | – |
Q2 2023 | $41 | -45.3% | 3,901 | -52.1% | 0.00% | – |
Q1 2023 | $75 | -42.3% | 8,148 | -44.2% | 0.00% | – |
Q4 2022 | $130 | -99.6% | 14,599 | +286.0% | 0.00% | – |
Q3 2022 | $31,000 | 0.0% | 3,782 | 0.0% | 0.00% | – |
Q2 2022 | $31,000 | -49.2% | 3,782 | -45.6% | 0.00% | – |
Q1 2022 | $61,000 | -88.3% | 6,951 | -87.3% | 0.00% | – |
Q4 2021 | $522,000 | +163.6% | 54,918 | +367.0% | 0.00% | – |
Q3 2021 | $198,000 | +94.1% | 11,760 | +75.5% | 0.00% | – |
Q2 2021 | $102,000 | -74.0% | 6,700 | -66.6% | 0.00% | – |
Q1 2021 | $392,000 | +105.2% | 20,068 | +89.7% | 0.00% | – |
Q4 2020 | $191,000 | -24.2% | 10,578 | -19.0% | 0.00% | – |
Q3 2020 | $252,000 | -38.8% | 13,058 | -17.1% | 0.00% | – |
Q2 2020 | $412,000 | +122.7% | 15,751 | +51.7% | 0.00% | – |
Q1 2020 | $185,000 | -72.0% | 10,384 | -47.4% | 0.00% | – |
Q4 2019 | $660,000 | +178.5% | 19,753 | +98.4% | 0.00% | – |
Q3 2019 | $237,000 | -45.6% | 9,954 | -17.9% | 0.00% | – |
Q2 2019 | $436,000 | -61.4% | 12,126 | -60.3% | 0.00% | -100.0% |
Q1 2019 | $1,129,000 | +23.3% | 30,563 | +43.6% | 0.00% | 0.0% |
Q4 2018 | $916,000 | -3.1% | 21,281 | +6.4% | 0.00% | 0.0% |
Q3 2018 | $945,000 | -15.9% | 20,000 | -11.5% | 0.00% | 0.0% |
Q2 2018 | $1,124,000 | -9.5% | 22,600 | -9.6% | 0.00% | 0.0% |
Q1 2018 | $1,242,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |